NIH-funded research R21 grant

How signals affect muscle stem cells during injury recovery

Official title: Regulation of Muscle Stem Cells by Netrin Signaling

Funded at Icahn School of Medicine at Mount Sinai · NIH-11143182 · Data updated 2026-11-12

This study is looking at how special muscle cells help heal injuries in our muscles and what makes them wake up and start working when we need repair, which could lead to new ways to help people recover from muscle damage.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2024
Project endMay 31, 2026
Funding year2025
Award (this year)$180,323
NIH project number5R21AR084632-02
Project IDNIH-11143182 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who have experienced muscle injuries or conditions affecting muscle regeneration.

Less likely to help

Patients with chronic muscle diseases or those who do not have muscle injuries may not benefit from this research.

What this research studies

This research investigates the role of muscle stem cells (MuSCs) in the regeneration of skeletal muscle after injury. It focuses on understanding how these cells maintain a resting state (quiescence) and what triggers their activation to repair damaged muscle. The study will explore the cellular mechanisms and signals from the surrounding environment that influence MuSC behavior, particularly during the transition from quiescence to activation. By identifying these signals, the research aims to uncover new therapeutic targets for enhancing muscle repair.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for muscle injuries and degenerative conditions, enhancing recovery and muscle function.

How similar studies have gone: Previous research has shown promising results in understanding muscle stem cell dynamics, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Krauss, Robert S. — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Krauss, Robert S.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.